Save time and get answers to complex questions with AI chat
Mobic injection patent oehringer ingelheim france?Quartette side effects?What are the most memorable drug brands in oral factor b inhibitors? in united statesProlia and osteonecrosis?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for jornay
Jornay PM (generic name: methylphenidate) is used to treat attention-deficit/hyperactivity disorder (ADHD) in people who need symptom control throughout the day, including early morning hours. It’s designed to be taken in the evening so it can begin working by the next morning. [1]
Jornay PM is specifically indicated for ADHD. It’s not described here as a treatment for other conditions. [1]
For ADHD, Jornay PM is used to help reduce core symptoms such as: - Inattention (trouble focusing) - Hyperactivity - Impulsivity These are the main symptom areas targeted by ADHD treatment with methylphenidate formulations. [1]
Jornay PM is taken in the evening, with the goal of providing effects by the next morning. This timing is part of how it’s meant to fit the daily pattern of ADHD symptoms (including when someone is waking up and getting ready for school/work). [1]
Jornay PM is a specific extended-release methylphenidate product with evening dosing and a next-morning effect profile. Other ADHD methylphenidate products may have different release timing and dosing schedules, so the exact “when it works” pattern can differ by brand/product. [1]
Other Questions About Jornay :